HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Danilo Casimiro Selected Research

Acquired Immunodeficiency Syndrome (AIDS)

9/2010AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Danilo Casimiro Research Topics

Disease

6Infections
01/2022 - 05/2012
3Virus Diseases (Viral Diseases)
12/2021 - 01/2021
2Communicable Diseases (Infectious Diseases)
12/2021 - 01/2020
2COVID-19
12/2021 - 04/2021
2Tuberculosis (Tuberculoses)
01/2020 - 01/2018
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2022
1Human Influenza (Influenza)
12/2021
1Weight Loss (Weight Reduction)
04/2021
1Respiratory Tract Diseases (Respiratory Tract Disease)
04/2021
1Pulmonary Tuberculosis
01/2020
1Condylomata Acuminata (Genital Wart)
08/2019
1Neoplasms (Cancer)
08/2019
1Respiratory Syncytial Virus Infections
01/2016
1Acquired Immunodeficiency Syndrome (AIDS)
09/2010

Drug/Important Bio-Agent (IBA)

9VaccinesIBA
01/2022 - 09/2010
3Proteins (Proteins, Gene)FDA Link
03/2021 - 09/2010
2Neutralizing AntibodiesIBA
01/2022 - 01/2021
2Messenger RNA (mRNA)IBA
12/2021 - 01/2020
2BCG VaccineFDA Link
01/2020 - 01/2018
1AntibodiesIBA
01/2022
1Lipid NanoparticlesIBA
12/2021
1mRNA VaccinesIBA
12/2021
1AntigensIBA
12/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
12/2021
1Neuraminidase (Sialidase)IBA
12/2021
1Synthetic Vaccines (Recombinant Vaccines)IBA
08/2019
1Immediate-Early ProteinsIBA
12/2017
1PalivizumabFDA Link
01/2016
1HLA-DR Antigens (HLA-DR)IBA
05/2012

Therapy/Procedure

2Therapeutics
01/2022 - 01/2016
1Intravenous Administration
01/2020